A Second Act for Third-Party Pharma Auditing Anticipated
This article was originally published in The Gold Sheet
Executive Summary
FDA officials are looking at using the Food Safety Modernization Act as a model in developing a third-party review program for globally sourced drug products and ingredients. The recently enacted legislation would allow private third parties as well as foreign governments to conduct food safety inspections on behalf of FDA.
You may also be interested in...
User Fee Bill Puts Industry, U.S. FDA to Work On Global Supply Chain Risks
The user fee legislation U.S. Congress approved June 26 makes quality risk management a GMP requirement, further pressuring pharmaceutical manufacturers to make sure they are protecting their global supply chains.
User Fee Bill Puts Industry, FDA to Work on Supply Chain Risks
The user fee legislation Congress approved June 26 makes quality risk management a GMP requirement, further pressuring pharmaceutical manufacturers to make sure they are protecting their global supply chains. The bill directs FDA to inspect based on risk rather than time or location, and to rely on trusted foreign inspectorates, while adding new user fees for generic drugs that will boost funding for further expansion of the agency’s inspectorate.
FDA Considers Using Third-Party Inspectors to Enhance Global Reach
FDA is talking about adding an outsourced inspectorate to help it police the globally outsourced pharmaceutical manufacturing industry.